梅花生物
(600873)
| 流通市值：312.10亿 | | | 总市值：312.10亿 |
| 流通股本：28.53亿 | | | 总股本：28.53亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,913,757,715.41 | 3,015,835,017.01 | 4,561,056,193.96 | 3,635,044,488.5 |
| 交易性金融资产 | 1,397,826,972.26 | 1,947,574,011.81 | 312,033,611.07 | 2,017,646,136.26 |
| 衍生金融资产 | 468,200 | 670,200 | - | 1,474,430 |
| 应收票据及应收账款 | 700,229,883.25 | 734,446,720.77 | 661,607,013.51 | 751,131,144.42 |
| 其中：应收票据 | 92,822,653.44 | 51,758,511.88 | 73,697,475.3 | 92,702,023.7 |
| 应收账款 | 607,407,229.81 | 682,688,208.89 | 587,909,538.21 | 658,429,120.72 |
| 应收款项融资 | 18,045,534.34 | 30,772,302.09 | 26,723,054.99 | 48,434,635.02 |
| 预付款项 | 107,821,158 | 322,435,573.91 | 220,000,861.75 | 102,144,835.83 |
| 其他应收款合计 | 28,668,079.85 | 19,756,632.66 | 49,292,999.56 | 21,437,664.97 |
| 其中:应收利息 | 2,362,500 | 1,968,750 | 1,575,000 | 2,756,250 |
| 应收股利 | 1,395,866.49 | 1,395,866.49 | 1,395,866.49 | - |
| 存货 | 2,512,884,223.71 | 3,065,170,465.97 | 2,722,279,908.07 | 1,869,967,037 |
| 一年内到期的非流动资产 | 108,345,222.59 | 215,696,778.22 | 182,257,027.81 | - |
| 其他流动资产 | 1,053,547,103.85 | 147,030,689.15 | 164,629,398.67 | 202,345,542.87 |
| 流动资产合计 | 8,841,594,093.26 | 9,499,388,391.59 | 8,899,880,069.39 | 8,649,625,914.87 |
| 非流动资产: | | | | |
| 债权投资 | 10,500,000 | 10,500,000 | 10,500,000 | 10,500,000 |
| 长期应收款 | 619,712.6 | 605,867.91 | 601,043.91 | 604,363.87 |
| 长期股权投资 | 5,951,585.9 | 7,119,939.88 | 6,874,939.88 | 9,681,134.97 |
| 其他权益工具投资 | 327,534,650 | 348,487,225 | 441,294,280 | 559,649,235 |
| 固定资产 | 11,305,605,148.16 | 11,593,103,698.06 | 11,338,208,623.56 | 10,649,124,994.59 |
| 在建工程 | 1,133,239,020.75 | 445,413,073.39 | 728,524,141.54 | 1,195,320,655.53 |
| 使用权资产 | 5,686,811.92 | 7,238,996.47 | 8,145,892.35 | 9,612,015.81 |
| 无形资产 | 1,335,157,587.43 | 1,345,945,854.46 | 1,356,812,266.82 | 1,352,736,353.06 |
| 商誉 | 11,788,911.79 | 11,788,911.79 | 11,788,911.79 | 11,788,911.79 |
| 长期待摊费用 | 132,143,362.76 | 122,207,227.47 | 122,538,549.51 | 126,754,587.6 |
| 递延所得税资产 | 129,145,474.37 | 113,680,888.39 | 101,814,807.93 | 82,308,774.82 |
| 其他非流动资产 | 762,531,174.19 | 791,378,399.16 | 782,574,484.98 | 877,163,530.5 |
| 非流动资产合计 | 15,159,903,439.87 | 14,797,470,081.98 | 14,909,677,942.27 | 14,885,244,557.54 |
| 资产总计 | 24,001,497,533.13 | 24,296,858,473.57 | 23,809,558,011.66 | 23,534,870,472.41 |
| 流动负债: | | | | |
| 短期借款 | 1,586,838,913.18 | 1,682,300,239.99 | 1,734,832,631.06 | 2,151,399,649.73 |
| 衍生金融负债 | - | 99,600 | 297,500 | - |
| 应付票据及应付账款 | 3,000,809,893.71 | 2,744,688,982.67 | 2,857,750,606.68 | 2,742,093,000.67 |
| 其中：应付票据 | 1,423,949,868.69 | 1,274,734,112.07 | 1,416,217,579.96 | 1,344,044,311.96 |
| 应付账款 | 1,576,860,025.02 | 1,469,954,870.6 | 1,441,533,026.72 | 1,398,048,688.71 |
| 合同负债 | 656,660,453.8 | 704,476,996.09 | 916,515,321.35 | 1,042,732,971.32 |
| 应付职工薪酬 | 337,442,819.61 | 303,661,585.19 | 310,133,688.99 | 306,146,311.41 |
| 应交税费 | 250,775,388.2 | 325,380,565.13 | 280,212,685.6 | 148,670,678.04 |
| 其他应付款合计 | 242,540,793.08 | 248,621,093.28 | 448,115,137.98 | 187,779,277.18 |
| 应付股利 | 405,000 | 409,445.58 | 409,445.58 | 405,000 |
| 一年内到期的非流动负债 | 710,617,924.83 | 924,520,213.64 | 802,346,793.78 | 590,046,413.91 |
| 其他流动负债 | 61,495,237.41 | 57,540,051.8 | 88,785,123.74 | 100,046,251.51 |
| 流动负债合计 | 6,847,181,423.82 | 6,991,289,327.79 | 7,438,989,489.18 | 7,268,914,553.77 |
| 非流动负债: | | | | |
| 长期借款 | 1,732,115,654.12 | 1,412,761,764.93 | 1,348,094,044.83 | 1,077,339,750 |
| 租赁负债 | 1,557,058.76 | 1,751,984.98 | 1,985,140.84 | 2,003,939.56 |
| 长期应付款 | 10,500,000 | 10,500,000 | 10,500,000 | 36,983,005.63 |
| 预计负债 | 32,948,103.32 | 32,691,723.94 | 32,438,161.92 | 32,178,965.18 |
| 递延收益 | 375,510,410.61 | 374,678,509.41 | 381,020,645.51 | 371,878,831.47 |
| 递延所得税负债 | 21,550,168.28 | 21,722,813.35 | 21,585,228.45 | 27,529,902.79 |
| 非流动负债合计 | 2,174,181,395.09 | 1,854,106,796.61 | 1,795,623,221.55 | 1,547,914,394.63 |
| 负债合计 | 9,021,362,818.91 | 8,845,396,124.4 | 9,234,612,710.73 | 8,816,828,948.4 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,852,788,750 | 2,852,788,750 | 2,852,788,750 | 2,852,788,750 |
| 资本公积 | 263,154,867.05 | 263,154,867.05 | 263,154,867.05 | 263,154,867.05 |
| 减:库存股 | 352,066,338.78 | 352,066,338.78 | 287,771,455.8 | - |
| 其他综合收益 | -153,671,324.15 | -133,905,315.41 | -55,004,961.46 | 45,602,220.8 |
| 专项储备 | 4,931,483.03 | 5,749,534.39 | 4,743,615.67 | 5,328,736.71 |
| 盈余公积 | 1,426,394,375 | 1,426,394,375 | 1,426,394,375 | 1,326,294,444.3 |
| 未分配利润 | 10,938,602,902.07 | 11,389,346,476.92 | 10,370,640,110.47 | 10,224,872,505.15 |
| 归属于母公司股东权益合计 | 14,980,134,714.22 | 15,451,462,349.17 | 14,574,945,300.93 | 14,718,041,524.01 |
| 股东权益合计 | 14,980,134,714.22 | 15,451,462,349.17 | 14,574,945,300.93 | 14,718,041,524.01 |
| 负债和股东权益合计 | 24,001,497,533.13 | 24,296,858,473.57 | 23,809,558,011.66 | 23,534,870,472.41 |
| 公告日期 | 2025-08-20 | 2025-04-22 | 2025-03-18 | 2024-10-23 |
| 审计意见(境内) | | | 标准无保留意见 | |